Brian C. Thomas

Chief Executive Officer at Metagenomi Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2024

3 years of board service in total across 1 board, counting each seat separately. Longest: Metagenomi Therapeutics Inc., 2 years.

Metagenomi Therapeutics Inc. Director · Chief Executive Officer
2 years · Since 2024

Chief executive roles

Metagenomi Therapeutics Inc. · Chief Executive Officer
Since February 2024
0 CEO score

Weak · grade F

Out of 100, from shareholder return, dividends, growth and acquisitions.

Partial: only 20% of the scoring weight is on file.

Revenue growth 20%
0

-25% a year in revenue

20% of the scoring weight is on file. Figures cover December 2023 – December 2025.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Dec 5, 2025 Metagenomi Therapeutics Inc. Open-market sale −3,830 $1.77 $6,779
Sep 5, 2025 Metagenomi Therapeutics Inc. Open-market sale −2,701 $1.81 $4,889
Jun 6, 2025 Metagenomi Therapeutics Inc. Open-market sale −10,785 $1.75 $18,874
Apr 1, 2025 Metagenomi Therapeutics Inc. Grant or award +32,000 — —
Apr 1, 2024 Metagenomi Therapeutics Inc. Grant or award +118,992 — —

Questions about Brian C. Thomas

What boards is Brian C. Thomas on?

Brian C. Thomas sits on the board of Metagenomi Therapeutics Inc.

What company is Brian C. Thomas the CEO of?

Brian C. Thomas has been Chief Executive Officer of Metagenomi Therapeutics Inc. since February 2024.

How long has Brian C. Thomas served on boards?

Our records show at least 3 years of board service across 1 board, the earliest from 2024.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.